mortality/aging
• mutants die shortly after birth when doxycycline is administered throughout gestation
• in the absence of doxycycline treatment mutants are viable
|
respiratory system
• lung and airway malformations are seen when doxycycline exposure occurs between E0.5 and E13.5
• doxycycline exposure after E13.5 does not result in any pulmonary or extrapulmonary abnormalities
|
• branching morphogenesis is abnormal with doxycycline treatment
|
• lungs are hypoplastic after doxycycline exposure
|
• peripheral tubule dilation is seen with doxycycline exposure
|
• tracheal abnormalities are seen
• doxycycline exposure before E8.5 or after E13.5 does not result in tracheal abnormalities
|
• the cartilaginous rings that normal surround the trachea are malformed with incomplete rings found along the ventral midline after doxycycline exposure
|
• fewer cartilaginous rings are seen with doxycycline treatment
|
skeleton
• the cartilaginous rings that normal surround the trachea are malformed with incomplete rings found along the ventral midline after doxycycline exposure
|
• fewer cartilaginous rings are seen with doxycycline treatment
|
growth/size/body